# FDA Inspection 665013 - Binder Biomedical Inc - June 04, 2010

Source: https://www.keypedia.com/records/fda_inspections/binder-biomedical-inc/2a7e6964-e7c0-4f1c-9c9f-e367b2fe580e
Source feed: FDA_Inspections

> FDA Inspection 665013 for Binder Biomedical Inc on June 04, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 665013
- Company Name: Binder Biomedical Inc
- Inspection Date: 2010-06-04
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 708783 - 2011-02-04](https://www.keypedia.com/records/fda_inspections/binder-biomedical-inc/e14cd38f-56fc-4569-8eea-edfb65cafce3)
- [FDA Inspection 708783 - 2011-02-04](https://www.keypedia.com/records/fda_inspections/binder-biomedical-inc/52437f05-662d-44f6-bba1-330123ed4bf0)

Company: https://www.keypedia.com/companies/binder-biomedical-inc/eca8e434-5ada-40ac-a3fd-b95fefa3ca1d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d